Short answer
Nuvation Bio Inc. (NUVB) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 2025 earnings press release issued March 2, 2026: full financials in Exhibit 99.1.
Nuvation Bio Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 2025 earnings press release issued March 2, 2026: full financials in Exhibit 99.1
- Filing covers quarter ended December 31, 2025; no figures disclosed in this item directly
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nuvation Bio Inc. 8-K filings
Get the next NUVB 8-K as it lands
Follow NUVB for push alerts, or ask the research agent what this filing means.